These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 11850277)

  • 1. Activities of polymyxin B and cecropin A-,melittin peptide CA(1-8)M(1-18) against a multiresistant strain of Acinetobacter baumannii.
    Saugar JM; Alarcón T; López-Hernández S; López-Brea M; Andreu D; Rivas L
    Antimicrob Agents Chemother; 2002 Mar; 46(3):875-8. PubMed ID: 11850277
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative activities of cecropin A, melittin, and cecropin A-melittin peptide CA(1-7)M(2-9)NH2 against multidrug-resistant nosocomial isolates of Acinetobacter baumannii.
    Giacometti A; Cirioni O; Kamysz W; D'Amato G; Silvestri C; Del Prete MS; Łukasiak J; Scalise G
    Peptides; 2003 Sep; 24(9):1315-8. PubMed ID: 14706545
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Activity of cecropin A-melittin hybrid peptides against colistin-resistant clinical strains of Acinetobacter baumannii: molecular basis for the differential mechanisms of action.
    Saugar JM; Rodríguez-Hernández MJ; de la Torre BG; Pachón-Ibañez ME; Fernández-Reyes M; Andreu D; Pachón J; Rivas L
    Antimicrob Agents Chemother; 2006 Apr; 50(4):1251-6. PubMed ID: 16569836
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro activity of CA(1-8)M(1-18), a synthetic cecropin A-melittin hybrid peptide, against multiresistant Acinetobacter baumannii strains.
    Alarcón T; López-Hernández S; Andreu D; Saugar JM; Rivas L; López-Brea M
    Rev Esp Quimioter; 2001 Jun; 14(2):184-90. PubMed ID: 11704773
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Studies on the antimicrobial activity of cecropin A-melittin hybrid peptides in colistin-resistant clinical isolates of Acinetobacter baumannii.
    Rodríguez-Hernández MJ; Saugar J; Docobo-Pérez F; de la Torre BG; Pachón-Ibáñez ME; García-Curiel A; Fernández-Cuenca F; Andreu D; Rivas L; Pachón J
    J Antimicrob Chemother; 2006 Jul; 58(1):95-100. PubMed ID: 16636085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy of cecropin A-melittin peptides on a sepsis model of infection by pan-resistant Acinetobacter baumannii.
    López-Rojas R; Docobo-Pérez F; Pachón-Ibáñez ME; de la Torre BG; Fernández-Reyes M; March C; Bengoechea JA; Andreu D; Rivas L; Pachón J
    Eur J Clin Microbiol Infect Dis; 2011 Nov; 30(11):1391-8. PubMed ID: 21479973
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vitro activity of several antimicrobial peptides against colistin-susceptible and colistin-resistant Acinetobacter baumannii.
    Vila-Farres X; Garcia de la Maria C; López-Rojas R; Pachón J; Giralt E; Vila J
    Clin Microbiol Infect; 2012 Apr; 18(4):383-7. PubMed ID: 21672084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparative activities of polycationic peptides and clinically used antimicrobial agents against multidrug-resistant nosocomial isolates of Acinetobacter baumannii.
    Giacometti A; Cirioni O; Del Prete MS; Barchiesi F; Paggi AM; Petrelli E; Scalise G
    J Antimicrob Chemother; 2000 Nov; 46(5):807-10. PubMed ID: 11062203
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro double and triple synergistic activities of Polymyxin B, imipenem, and rifampin against multidrug-resistant Acinetobacter baumannii.
    Yoon J; Urban C; Terzian C; Mariano N; Rahal JJ
    Antimicrob Agents Chemother; 2004 Mar; 48(3):753-7. PubMed ID: 14982760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Shortened cecropin A-melittin hybrids. Significant size reduction retains potent antibiotic activity.
    Andreu D; Ubach J; Boman A; Wåhlin B; Wade D; Merrifield RB; Boman HG
    FEBS Lett; 1992 Jan; 296(2):190-4. PubMed ID: 1733777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retro and retroenantio analogs of cecropin-melittin hybrids.
    Merrifield RB; Juvvadi P; Andreu D; Ubach J; Boman A; Boman HG
    Proc Natl Acad Sci U S A; 1995 Apr; 92(8):3449-53. PubMed ID: 7724582
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The induction of NOS2 expression by the hybrid cecropin A-melittin antibiotic peptide CA(1-8)M(1-18) in the monocytic line RAW 264.7 is triggered by a temporary and reversible plasma membrane permeation.
    Arias C; Guizy M; Luque-Ortega JR; Guerrero E; de la Torre BG; Andreu D; Rivas L; Valenzuela C
    Biochim Biophys Acta; 2006 Jan; 1763(1):110-9. PubMed ID: 16377003
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antibacterial and antimalarial properties of peptides that are cecropin-melittin hybrids.
    Boman HG; Wade D; Boman IA; Wåhlin B; Merrifield RB
    FEBS Lett; 1989 Dec; 259(1):103-6. PubMed ID: 2689223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Activities of synthetic peptides against human pathogenic bacteria.
    Bogucka K; Królicka A; Kamysz W; Ossowski T; Lukasiak J; Lojkowska E
    Pol J Microbiol; 2004; 53(1):41-4. PubMed ID: 15330266
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibacterial peptides and mitochondrial presequences affect mitochondrial coupling, respiration and protein import.
    Hugosson M; Andreu D; Boman HG; Glaser E
    Eur J Biochem; 1994 Aug; 223(3):1027-33. PubMed ID: 8055943
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Permeabilization of the mitochondrial inner membrane by short cecropin-A-melittin hybrid peptides.
    Díaz-Achirica P; Prieto S; Ubach J; Andreu D; Rial E; Rivas L
    Eur J Biochem; 1994 Aug; 224(1):257-63. PubMed ID: 8076647
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure-antibacterial, antitumor and hemolytic activity relationships of cecropin A-magainin 2 and cecropin A-melittin hybrid peptides.
    Shin SY; Kang JH; Hahm KS
    J Pept Res; 1999 Jan; 53(1):82-90. PubMed ID: 10195445
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of polymyxin B and meropenem eradicates persister cells from Acinetobacter baumannii strains in exponential growth.
    Gallo SW; Ferreira CAS; de Oliveira SD
    J Med Microbiol; 2017 Aug; 66(8):1257-1260. PubMed ID: 28721845
    [No Abstract]   [Full Text] [Related]  

  • 19. Antimicrobial peptides as a promising treatment option against Acinetobacter baumannii infections.
    Neshani A; Sedighian H; Mirhosseini SA; Ghazvini K; Zare H; Jahangiri A
    Microb Pathog; 2020 Sep; 146():104238. PubMed ID: 32387392
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Highly Synergistic Effects of Melittin with Conventional Antibiotics Against Multidrug-Resistant Isolates of Acinetobacter baumannii and Pseudomonas aeruginosa.
    Akbari R; Hakemi-Vala M; Pashaie F; Bevalian P; Hashemi A; Pooshang Bagheri K
    Microb Drug Resist; 2019 Mar; 25(2):193-202. PubMed ID: 30281385
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.